• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

iScience . Screening and characterization of inhibitory vNAR targeting nanodisc-assembled influenza M2 proteins

tetano

Editor, Senior Moderator
iScience


. 2022 Dec 5;26(1):105736.
doi: 10.1016/j.isci.2022.105736. eCollection 2023 Jan 20.
Screening and characterization of inhibitory vNAR targeting nanodisc-assembled influenza M2 proteins


Chuandi Yu[SUP] 1 2 [/SUP], Wen Ding[SUP] 3 [/SUP], Lei Zhu[SUP] 1 [/SUP], Yuhang Zhou[SUP] 4 [/SUP], Yingkui Dong[SUP] 1 5 [/SUP], Ling Li[SUP] 1 [/SUP], Juanjuan Liu[SUP] 1 [/SUP], Yizhuo Wang[SUP] 1 2 [/SUP], Zehua Li[SUP] 1 2 [/SUP], Lina Zhu[SUP] 1 2 [/SUP], FaJun Chen[SUP] 1 3 [/SUP], Maosen Ruan[SUP] 1 [/SUP], Dongming Qian[SUP] 6 [/SUP], Yujuan Wang[SUP] 1 [/SUP], Bo Wu[SUP] 1 [/SUP], Huangtao Xu[SUP] 1 [/SUP], Ming Li[SUP] 1 2 [/SUP], Yunchen Bi[SUP] 7 8 [/SUP], Hao Wang[SUP] 7 8 [/SUP], Weiqian Wang[SUP] 9 [/SUP], Peng Chao[SUP] 9 [/SUP], Lei Xing[SUP] 1 2 [/SUP], Bing Shen[SUP] 3 [/SUP], Han Dai[SUP] 1 [/SUP], Lisha Zha[SUP] 4 [/SUP], Hongxin Zhao[SUP] 1 6 [/SUP], Junfeng Wang[SUP] 1 2 5 [/SUP]



Affiliations
Free PMC article

Abstract

Influenza A virus poses a constant challenge to human health. The highly conserved influenza matrix-2 (M2) protein is an attractive target for the development of a universal antibody-based drug. However, screening using antigens with subphysiological conformation in a nonmembrane environment significantly reduces the generation of efficient antibodies. Here, M2(1-46) was incorporated into nanodiscs (M2-nanodiscs) with M2 in a membrane-embedded tetrameric conformation, closely resembling its natural physiological state in the influenza viral envelope. M2-nanodisc generation, an antigen, was followed by Chiloscyllium plagiosum immunization. The functional vNARs were selected by phage display panning strategy from the shark immune library. One of the isolated vNARs, AM2H10, could specifically bind to tetrameric M2 instead of monomeric M2e (the ectodomain of M2 protein). Furthermore, AM2H10 blocked ion influx through amantadine-sensitive and resistant M2 channels. Our findings indicated the possibility of developing functional shark nanobodies against various influenza viruses by targeting the M2 protein.

Keywords: Nanoparticles; Virology.
 
Back
Top